Patent · US Active

Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and use

US12281098B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

Hangzhou Polymed Biopharmaceuticals, Inc. · CN

Inventors

Jason Shaoyun Xiang · Winchester, US
Lei Wu · San Diego, US
Rui Xu · Boulder, US
Qiang Zhang · Dalian, CN
Gang Yang · Nanhu, CN
Michael Xiang · Zhejiang, CN
Mixue Tong · Zhejiang, CN
Camille Xiang · Zhejiang, CN
Suyue Wang · Hangzhou City, CN
Rui Yang · Jiaocheng District, CN

Key dates

Filing date	Apr 11, 2024
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Apr 11, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A five-membered-fused six-membered compound, a preparation method, a pharmaceutical composition, and the use. The penta-fused hexa-heterocyclic compound is a compound represented by formula (II) or (III). The compound has an inhibition or/and degradation effect on IRAK4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.